Dodich, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 3.182
EU - Europa 1.949
AS - Asia 1.353
SA - Sud America 362
AF - Africa 38
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.905
Nazione #
US - Stati Uniti d'America 3.107
IT - Italia 925
SG - Singapore 676
CN - Cina 343
BR - Brasile 301
RU - Federazione Russa 229
DE - Germania 210
FI - Finlandia 120
NL - Olanda 104
VN - Vietnam 92
GB - Regno Unito 69
LV - Lettonia 62
CA - Canada 42
HK - Hong Kong 41
BG - Bulgaria 40
ID - Indonesia 38
FR - Francia 35
JO - Giordania 35
IN - India 32
MX - Messico 24
AR - Argentina 22
UA - Ucraina 21
ES - Italia 18
AU - Australia 16
SE - Svezia 16
GR - Grecia 15
AT - Austria 14
BD - Bangladesh 12
CL - Cile 12
CH - Svizzera 11
JP - Giappone 11
PL - Polonia 11
TN - Tunisia 11
EC - Ecuador 10
IQ - Iraq 10
KR - Corea 10
HR - Croazia 8
TR - Turchia 8
AL - Albania 7
IR - Iran 7
MA - Marocco 7
PE - Perù 7
PT - Portogallo 7
ZA - Sudafrica 7
CO - Colombia 6
BE - Belgio 5
CR - Costa Rica 4
HU - Ungheria 4
LT - Lituania 4
PH - Filippine 4
PK - Pakistan 4
SA - Arabia Saudita 4
DZ - Algeria 3
IE - Irlanda 3
JM - Giamaica 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
RS - Serbia 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
IL - Israele 2
KZ - Kazakistan 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
FJ - Figi 1
GA - Gabon 1
KE - Kenya 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.905
Città #
Singapore 435
Ashburn 426
Dallas 282
Fairfield 270
Chandler 238
Santa Clara 173
Munich 148
Woodbridge 129
Seattle 120
Houston 113
Milan 112
Columbus 108
Trento 108
Princeton 107
Cambridge 100
Moscow 95
Wilmington 90
Beijing 84
Helsinki 81
Rome 69
Los Angeles 68
Riga 62
Sofia 39
Bassano del Grappa 34
Hong Kong 34
San Diego 34
Ho Chi Minh City 33
New York 33
San Mateo 32
Buffalo 31
Jakarta 31
Boardman 29
Chicago 28
Hefei 26
Ann Arbor 25
Nuremberg 24
North Bergen 22
Hanoi 20
São Paulo 20
The Dalles 20
Amsterdam 18
Redondo Beach 18
Verona 17
London 16
Turku 16
Council Bluffs 15
Montreal 15
Shanghai 15
Florence 14
Padova 14
Rio de Janeiro 14
Lappeenranta 13
Orem 13
Bolzano 12
Denver 12
Phoenix 12
Bologna 11
Palermo 11
Tokyo 11
Toronto 11
Andover 10
Boston 10
Lawrence 10
Manchester 10
Poplar 10
Warsaw 10
Washington 9
Belo Horizonte 8
Falkenstein 8
Genoa 8
Mexico City 8
Mumbai 8
Naples 8
Norwalk 8
Padua 8
Recife 8
Tunis 8
Zhengzhou 8
Zurich 8
Cagliari 7
Curitiba 7
Falls Church 7
Shenzhen 7
Tirana 7
Athens 6
Brasília 6
Elk Grove Village 6
Guangzhou 6
Paris 6
Pittsburgh 6
Querétaro 6
Salt Lake City 6
San Francisco 6
Stockholm 6
Thessaloniki 6
Thái Bình 6
Trieste 6
Vancouver 6
Baghdad 5
Brescia 5
Totale 4.505
Nome #
The FACE test: a new neuropsychological task to assess the recognition of complex mental states from faces 592
The Role of Social Cognition Abilities in Parkinson's Disease in the Era of COVID-19 Emergency 266
The Social and Cognitive Online Training (SCOT) project: A digital randomized controlled trial to promote socio-cognitive well-being in older adults 180
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 156
A biomarker study in long-lasting amnestic mild cognitive impairment 153
Diffusion tensor imaging evidence of corticospinal pathway involvement in frontotemporal lobar degeneration 122
Deficits in Emotion Recognition and Theory of Mind in Parkinson's Disease Patients With and Without Cognitive Impairments 117
Experience and needs of Italian clinicians on the use of Social cognition measures in neurocognitive patients: the joint work of the SIGNATURE consortium 112
Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework 106
Tango and physiotherapy interventions in Parkinson’s disease: a pilot study on efficacy outcomes on motor and cognitive skills 105
Lockdown effects on Parkinson’s disease during COVID-19 pandemic: a pilot study 105
Connectome-based fingerprint of motor impairment is stable along the course of Parkinson’s disease 103
The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy 103
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 103
Alterations in moral cognition in Parkinson’s disease and its association with socio-cognitive functions 102
Covid-19 Outbreak In Italy: Are We Ready for the Psychosocial and the Economic Crisis? Baseline Findings From the PsyCovid Study 102
Mental State Recognition Deficits Linked to Brain Changes in Parkinson's Disease Without Dementia 99
Evaluation of Discriminative Detection Abilities of Social Cognition Measures for the Diagnosis of the Behavioral Variant of Frontotemporal Dementia: a Systematic Review 98
Emotion Recognition Deficits in the Differential Diagnosis of Amnestic Mild Cognitive Impairment: A Cognitive Marker for the Limbic-Predominant Phenotype 92
Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework 92
A novel task assessing intention and emotion attribution: Italian standardization and normative data of the Story-based Empathy Task 91
Individual Brain Metabolic Signatures in Corticobasal Syndrome 91
Short-term Sahaja Yoga meditation training modulates brain structure and spontaneous activity in the executive control network 90
Qualitative Scoring of the Pentagon Test: A Tool for the Identification of Subtle Cognitive Deficits in Isolated REM Sleep Behavior Disorder Patients 87
Diagnostic Accuracy of Affective Social Tasks in the Clinical Classification between the Behavioral Variant of Frontotemporal Dementia and Other Neurodegenerative Disease 87
Moral Cognition and Multiple Sclerosis: A Neuropsychological Study 86
Early Identification of Different Behavioral Phenotypes in the Behavioral Variant of Frontotemporal Dementia with the Aid of the Mini-Frontal Behavioral Inventory (mini-FBI) 84
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 83
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework 83
A digital teleneuropsychology platform for the diagnosis of mild cognitive impairment: from concept to certification as a medical device 82
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework 82
The SCOT project: A multi-componential intervention to reduce loneliness in the elderly population 81
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 81
Functional alterations in resting-state networks for Theory of Mind in Parkinson's disease 80
Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study 80
The A/T/N model applied through imaging biomarkers in a memory clinic 79
Job loss and health threatening events modulate risk-taking behaviours in the Covid-19 emergency 78
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison 74
Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 48, 7, (2070-2085), 10.1007/s00259-020-05120-2) 71
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers 70
The SCOT project: a Social and Cognitive Online Training to promote active ageing 68
Affective mentalizing and brain activity at rest in the behavioral variant of frontotemporal dementia 66
Answer to “Social cognition assessment for mild neurocognitive disorders” 65
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 65
Answer to "Current Potential for Clinical Optimization of Social Cognition Assessment for Frontotemporal Dementia and Primary Psychiatric Disorders" 64
Moral cognition in Parkinson’s Disease patients and its association with socio-cognitive functions 64
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 64
Are we…social enough? Results from a survey on the use of social networks within the “SINdem” community 63
Brain changes within the visuo-spatial attentional network in posterior cortical atrophy 61
Mini-Frontal Behavioral Inventory supports early identification of different behavioral phenotypes in the behavioral variant of frontotemporal dementia 59
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 55
Combined socio-behavioral evaluation improves the differential diagnosis between the behavioral variant of frontotemporal dementia and Alzheimer's disease: In search of neuropsychological markers 54
null 53
Unraveling Moral Reasoning in Amyotrophic Lateral Sclerosis: How Emotional Detachment Modifies Moral Judgment 53
Identifying Frail Populations for Disease Risk Prediction and Intervention Planning in the Covid-19 Era: A Focus on Social Isolation and Vulnerability 53
Dementia prevention in memory clinics: recommendations from the European task force for brain health services 51
Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment 49
null 49
null 49
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 48
Risk-Aversion for Negative Health Outcomes May Promote Individual Compliance to Containment Measures in Covid-19 Pandemic 48
null 47
null 47
Weighing the role of social cognition and executive functioning in pragmatics in the schizophrenia spectrum: A systematic review and meta-analysis 47
null 46
null 46
null 46
null 45
null 45
Large-Scale Functional Networks, Cognition and Brain Structures Supporting Social Cognition and Theory of Mind Performance in Prodromal to Mild Alzheimer’s Disease 43
null 43
The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update 43
Emotional empathy in amyotrophic lateral sclerosis: a behavioural and voxel-based morphometry study 42
null 42
null 42
null 42
null 41
null 41
null 40
null 40
Predictor model for mild cognitive impairment in Parkinson’s disease using visual rating scales 38
null 37
null 37
Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease 36
Transdiagnostic overlap in brain correlates of affective and cognitive theory of mind deficits 36
The emerging field of non-invasive brain stimulation in Alzheimer's disease 36
Self-Assessment of Empathy Uncovers Defective Self-Awareness in Mild Cognitive Impairment 34
null 34
Correction to: A digital teleneuropsychology platform for the diagnosis of mild cognitive impairment: from concept to certification as a medical device (Neurological Sciences, (2024), 45, 7, (3125-3135), 10.1007/s10072-024-07403-0) 33
The role of single-subject brain metabolic patterns in the early differential diagnosis of primary progressive aphasias and in prediction of progression to dementia 31
The role of sex and education in the clinical manifestation and progression of Posterior Cortical Atrophy. 28
Social cognition dysfunctions in patients with epilepsy: Evidence from patients with temporal lobe and idiopathic generalized epilepsies 27
Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia 25
Diagnostic Performance of Socio-Emotional Informant-Based Questionnaires for the Clinical Detection of the Behavioral Variant of Frontotemporal Dementia 22
Perceived social isolation is associated with altered functional connectivity in neural networks associated with tonic alertness and executive control 21
Motor neuron dysfunctions in the frontotemporal lobar degeneration spectrum: A clinical and neurophysiological study 20
Understanding barriers and optimizing socio-cognitive assessment in the diagnosis of neurocognitive disorders 20
When Sex Overcomes Motor Phenotype: New Evidence on Cognitive and Neurobehavioral Symptoms in Parkinson's Disease 20
Right limbic FDG-PET hypometabolism correlates with emotion recognition and attribution in probable behavioral variant of frontotemporal dementia patients 20
Improving innovative decision-making: Training-induced changes in fronto-parietal networks 19
Totale 7.151
Categoria #
all - tutte 30.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021272 0 0 0 0 0 25 47 63 10 65 31 31
2021/2022443 31 32 5 19 7 77 34 51 32 48 12 95
2022/2023670 111 40 24 60 38 83 49 59 114 7 41 44
2023/2024606 22 44 34 20 38 56 31 12 10 187 44 108
2024/20252.255 59 31 131 277 156 296 164 147 260 297 238 199
2025/20262.299 318 137 576 627 446 195 0 0 0 0 0 0
Totale 7.219